Tuesday, June 30, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

LTRN — Lantern Pharma Inc. SEC Filings | FilingIndex

LTRNNasdaq

Lantern Pharma Inc.

Pharmaceutical Preparations · TX · CIK 1763950

Lantern Pharma Inc. uses AI to discover and develop cancer therapies faster and cheaper

+ Watch View on EDGAR ↗

$50M

Market cap

$4.07

Last close

+5.4%

1D

+4.9%

5D

263K

Volume

Price · last 39 sessions+82.5%

May 4L $2.04 · H $4.07Jun 29

101

Total filings

Jun 12, 2026

Last filing

12/31

Fiscal year end

All 8-K · 51 10-Q · 18 10-K · 6 DEF 14A · 5 SC 13G · 3 SC 13D/A · 3 424B5 · 3 S-1/A · 3

S-1S-1Jun 12, 2026 8-KReg FD DisclosureJun 2, 2026 8-KResults of OperationsMay 15, 2026 10-Q10-QMay 15, 2026 SC 13D/ASC 13D/AMay 15, 2026 8-K

Similar companies

Comparable business profile · signals at a glance

WHWKWhitehawk Therapeutics, Inc.$205.7M+6.0%IMRXImmuneering Corp$271.1M+6.1%AVBPArriVent BioPharma, Inc.$1.4B+1.1%STROSUTRO BIOPHARMA, INC.$477.2M+9.3%CSBRCHAMPIONS ONCOLOGY, INC.

Material Agreement · Equity Issuance

May 14, 2026

424B5424B5May 14, 2026

10-K/A10-K/AApr 30, 2026

SC 13D/ASC 13D/AApr 16, 2026

8-KReg FD DisclosureApr 10, 2026

424B5424B5Mar 30, 2026

10-K10-KMar 30, 2026

8-KResults of Operations · Reg FD DisclosureMar 30, 2026

SC 13D/ASC 13D/AFeb 23, 2026

8-KReg FD DisclosureJan 23, 2026

8-KResults of Operations · Reg FD DisclosureNov 13, 2025

10-Q10-QNov 12, 2025

8-KShareholder VoteSep 23, 2025

8-KResults of OperationsAug 13, 2025

10-Q10-QAug 13, 2025

DEF 14ADEF 14AAug 8, 2025

8-KExecutive Change · Bylaw AmendmentJul 29, 2025

8-KMaterial AgreementJul 3, 2025

424B5424B5Jul 3, 2025

10-Q10-QMay 15, 2025

8-KResults of Operations · Reg FD DisclosureMay 15, 2025

10-K/A10-K/AApr 30, 2025

10-K10-KMar 27, 2025

8-KResults of Operations · Reg FD DisclosureMar 27, 2025

8-KExecutive ChangeJan 10, 2025

8-KReg FD DisclosureNov 8, 2024

10-Q10-QNov 7, 2024

8-KResults of OperationsNov 7, 2024

10-Q10-QAug 8, 2024

8-KResults of Operations · Reg FD DisclosureAug 8, 2024

8-KShareholder VoteJun 17, 2024

8-KBylaw AmendmentMay 24, 2024

10-Q10-QMay 9, 2024

8-KResults of Operations · Reg FD DisclosureMay 9, 2024

DEF 14ADEF 14AApr 29, 2024

10-K10-KMar 18, 2024

8-KResults of Operations · Reg FD DisclosureMar 18, 2024

8-KExecutive ChangeDec 29, 2023

8-KMaterial AgreementNov 24, 2023

10-Q10-QNov 8, 2023

8-KResults of Operations · Reg FD DisclosureNov 8, 2023

8-KCompany UpdateOct 20, 2023

10-Q10-QAug 9, 2023

8-KResults of Operations · Reg FD DisclosureAug 9, 2023

8-KShareholder VoteJun 21, 2023

8-KResults of Operations · Reg FD DisclosureMay 9, 2023

10-Q10-QMay 9, 2023

DEF 14ADEF 14AApr 28, 2023

10-K10-KMar 20, 2023

8-KResults of Operations · Reg FD DisclosureMar 20, 2023

8-KExecutive ChangeJan 18, 2023

10-Q10-QNov 7, 2022

8-KResults of Operations · Reg FD DisclosureNov 7, 2022

10-Q10-QAug 8, 2022

8-KResults of Operations · Reg FD DisclosureAug 8, 2022

8-KShareholder VoteJun 14, 2022

DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 3, 2022

10-QQUARTERLY REPORTMay 3, 2022

8-KResults of Operations · Reg FD DisclosureMay 3, 2022

DEF 14ADEFINITIVE PROXY STATEMENTApr 27, 2022

8-KExecutive Change · Reg FD DisclosureApr 26, 2022

8-KCompany UpdateApr 25, 2022

8-KCompany UpdateMar 22, 2022

10-KANNUAL REPORTMar 10, 2022

8-KResults of Operations · Reg FD DisclosureMar 10, 2022

8-KCompany UpdateJan 24, 2022

8-KCompany UpdateNov 22, 2021

10-QQUARTERLY REPORTNov 1, 2021

8-KResults of Operations · Reg FD DisclosureNov 1, 2021

10-QQUARTERLY REPORTJul 29, 2021

8-KResults of Operations · Reg FD DisclosureJul 29, 2021

8-KShareholder VoteMay 25, 2021

8-KResults of Operations · Reg FD DisclosureMay 3, 2021

10-QQUARTERLY REPORTMay 3, 2021

DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 9, 2021

$90.3M

-3.0%

LIXTLIXTE BIOTECHNOLOGY HOLDINGS, INC.$107.6M+11.8%